20-02-2023, 13:25

Novartis announces the appointment of the

Gilbert Ghostine, CEO of the Swiss multi-national fragrances business Firmenich appointed Chairman-Designate of the
Globe Newswire20-02-2023, 13:25
6-02-2023, 13:20

Sandoz Biologics License Application for proposed

Submission supported by comprehensive analytical and clinical data package Denosumab indicated for treating variety of
Globe Newswire6-02-2023, 13:20
4-02-2023, 06:41

Patients with hidradenitis suppurativa experienced

In two of the largest Phase III trials conducted in hidradenitis suppurativa (HS), Cosentyx® (secukinumab) treatment
Globe Newswire4-02-2023, 06:41
30-01-2023, 13:17

Sandoz receives positive CHMP opinion for citrate-free high

Sandoz is seeking approval of high concentration formulation (HCF) adalimumab for use in all indications of reference
Globe Newswire30-01-2023, 13:17